Insider Transactions in Q1 2024 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
215,991
-15.64%
|
$2,159,910
$10.54 P/Share
|
|
Mar 30
2024
|
Matthew Gline CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
390,579
+22.05%
|
-
|
|
Mar 30
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
366,211
-9.11%
|
$3,662,110
$10.54 P/Share
|
|
Mar 30
2024
|
Mayukh Sukhatme Pres&Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
729,081
+15.36%
|
-
|
|
Mar 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,341
-0.87%
|
$23,410
$10.54 P/Share
|
|
Mar 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.09%
|
$109,450
$10.01 P/Share
|
|
Mar 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.8%
|
$15,060
$10.01 P/Share
|
|
Mar 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,003
-3.1%
|
$160,030
$10.01 P/Share
|
|
Mar 07
2024
|
Keith S Manchester |
SELL
Other acquisition or disposition
|
Indirect |
30,257,723
-41.49%
|
-
|
|
Mar 07
2024
|
Daniel Allen Gold |
SELL
Other acquisition or disposition
|
Indirect |
45,821,757
-42.58%
|
-
|
|
Mar 07
2024
|
Qvt Financial LP |
SELL
Other acquisition or disposition
|
Indirect |
45,821,757
-42.58%
|
-
|
|
Feb 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-0.6%
|
$17,930
$11.71 P/Share
|
|
Feb 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.08%
|
$120,395
$11.54 P/Share
|
|
Feb 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,002
-3.01%
|
$176,022
$11.54 P/Share
|
|
Feb 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,508
-0.79%
|
$16,588
$11.54 P/Share
|
|
Feb 09
2024
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
96,950
-15.41%
|
$969,500
$10.92 P/Share
|
|
Feb 09
2024
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,950
+13.35%
|
$290,850
$3.85 P/Share
|
|
Jan 28
2024
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,896
-0.69%
|
$18,960
$10.37 P/Share
|
|
Jan 20
2024
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,377
-2.27%
|
$123,770
$10.35 P/Share
|
|
Jan 20
2024
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.07%
|
$109,450
$10.35 P/Share
|
|
Jan 20
2024
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.78%
|
$15,060
$10.35 P/Share
|
|
Jan 19
2024
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
3,366
+4.12%
|
-
|
|
Jan 19
2024
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,207
+5.31%
|
-
|
|
Jan 19
2024
|
Meghan Fitzgerald |
BUY
Grant, award, or other acquisition
|
Direct |
1,328
+9.48%
|
-
|
|
Jan 19
2024
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,570
+2.02%
|
-
|
|
Jan 02
2024
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,000,000
-5.46%
|
$33,000,000
$11.05 P/Share
|